| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |